by [email protected] | Mar 7, 2023 | Cardiovascular Posters, Presentations
Abstract Background: There is a paucity of real-world studies examining stroke/systemic embolism (S/SE) and major bleeding (MB) risks among non-valvular atrial fibrillation (NVAF) patients who switched from warfarin to a direct oral anticoagulant. Methods: A...
by [email protected] | Mar 7, 2023 | Cardiovascular Posters, Presentations
Abstract Background: Oral anticoagulants (OACs) reduce stroke risk in atrial fibrillation (AF) patients. Little is known about the differential prescription patterns of OACs and outcomes in AF patients when categorized by male versus female sex. The primary objectives...
by [email protected] | Mar 7, 2023 | Cardiovascular Posters, Presentations
Abstract Background: Oral anticoagulants (OACs) reduce stroke risk in atrial fibrillation (AF) patients. Little is known about the prescription patterns of OAC prescription and outcomes in AF patients among different age groups. The primary objectives of this study...
by [email protected] | Dec 12, 2022 | Cardiovascular Posters, Hematology Posters, Presentations
Click here to view abstract. Click here to view more of our presentations.
by [email protected] | Sep 15, 2022 | Cardiovascular Posters, Presentations
Abstract Background: Patients with venous thromboembolism (VTE) and cancer are at higher risk of adverse outcomes (mortality, recurrent VTE etc.) vs patients with cancer alone; as such, clinical guidelines recommend anticoagulant treatment for patients with VTE and...
by [email protected] | Aug 19, 2022 | Cardiovascular Posters, Presentations
Abstract Background Clinical guidelines recommend direct oral anticoagulants over vitamin-K antagonists for treatment of venous thromboembolism (VTE); however, there are no specific recommendations for VTE treatment inpatients with thrombophilia. Aims 5 US healthcare...
